TARSA THERAPEUTICS
Tarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that slows the rate of bone destruction.
TARSA THERAPEUTICS
Industry:
Biotechnology Medical Medical Device
Founded:
2009-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.tarsatherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
267-273-7940
Total Funding:
124.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
![]()
NeurogesX
NeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain.
Current Advisors List
![]()
![]()
![]()
![]()
Current Employees Featured

![]()
![]()

Founder
![]()
Investors List
Square 1 Bank
Square 1 Bank investment in Debt Financing - Tarsa Therapeutics
![]()
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - Tarsa Therapeutics
Foresite Capital
Foresite Capital investment in Series B - Tarsa Therapeutics
![]()
Novo Holdings
Novo Holdings investment in Series B - Tarsa Therapeutics
![]()
Quaker Partners
Quaker Partners investment in Series B - Tarsa Therapeutics
![]()
MVM Life Science Partners
MVM Life Science Partners investment in Series B - Tarsa Therapeutics
Foresite Capital
Foresite Capital investment in Series B - Tarsa Therapeutics
![]()
MVM Life Science Partners
MVM Life Science Partners investment in Series B - Tarsa Therapeutics
![]()
Marker
Marker investment in Series B - Tarsa Therapeutics
![]()
Quaker BioVentures
Quaker BioVentures investment in Series B - Tarsa Therapeutics
Official Site Inspections
http://www.tarsatherapeutics.com
- Host name: redirect-v225.secureserver.net
- IP address: 184.168.47.225
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
